Inpatient to Outpatient Transfer of Care in Urban Patients with Diabetes: Patterns and Determinants of Immediate Postdischarge Follow-up

Archives of Internal Medicine

Volumn 164, Issue 4, 2004, Pages 447-453

  Wheeler, Kate ^a   Crawford, Rochanda ^a   McAdams, Debra ^a   Benel, Sonia ^a   Dunbar, Virginia G ^a   Caudle, Jane M ^a   George, Christopher ^a   El Kebbi, Imad ^a   Gallina, Daniel L ^a   Ziemer, David C ^a   Cook, Curtiss B ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGE; AMBULATORY CARE; ARTICLE; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRONICS; FEMALE; FOLLOW UP; HEALTH SURVEY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URBAN POPULATION;

ADULT; AFTERCARE; AMBULATORY CARE; CONTINUITY OF PATIENT CARE; DIABETES MELLITUS; FEMALE; GEORGIA; HOSPITALS, MUNICIPAL; HUMANS; LOGISTIC MODELS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; URBAN POPULATION; UTILIZATION REVIEW;

EID: 10744229954     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.4.447     Document Type: Article

References (48)

1. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990-1998. Diabetes Care. 2000;23:1278-1283.
2. Nathan DM. Long term complications of diabetes mellitus. N Engl J Med. 1993 328;1676-1685.
3. Centers for Disease Control and Prevention. The public health burden of diabetes mellitus in the United States. In: Diabetes Surveillance, 1997. Washington, DC: US Dept of Health and Human Services; 1997:1-14.
4. Rubin RJ, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab. 1994;78:809A-809F.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
6. United Kingdom Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
7. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
8. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
9. Haffner SM, Alexander CM, Cook TJ, et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analysis in the Scandinavian Simvastatin Survival Study. Arch Intern Med. 1999;159:2661-2667.
10. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. Ophthalmology. 1981;88:583-600.
11. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE Study and MICRO-HOPE Substudy. Lancet. 2000;355:253-259.
12. ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA. 1992;268:1292-1300.
13. Aubert RE, Geiss LS, Ballard DJ, Cocanougher B, Herman WH. Diabetes-related hospitalization and hospital utilization. In: Diabetes in America. Washington, DC: National Institutes of Diabetes and Digestive Diseases; 1995:553-563.
14. Edelstein EL, Cesta TG. Nursing case management: an innovative model of care for hospitalized patients with diabetes. Diabetes Educator. 1993;19:517-521.
15. Roman S, Chassin MR. Windows of opportunity to improve diabetes care when patients with diabetes are hospitalized for other conditions. Diabetes Care. 2001;24:1371-1376.
16. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
17. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetes patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-360.
18. Van Den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
19. Ray NF, Thamer M, Taylor T, Fehrenback SN, Ratner R. Hospitalizations and expenditures for the treatment of general medical conditions among the US diabetic population in 1991. J Clin Endocrinol Metab. 1996;81:3671-3679.
20. Selby J, Zhang D, Ray NF, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396-1402.
21. Janes GR. Ambulatory medical care for diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health; 1995:541-552.
22. Scott RS, Brown LJ, Clifford P. Use of health services by diabetic persons, II: hospital admissions. Diabetes Care. 1985;8:43-46.
23. Gruesser M, Bott U, Ellerman P, Kronsbein P, Joergens, V. Evaluation of a structured treatment and teaching program for non-insulin-treated type II diabetic out-patients in Germany after the nationwide introduction of reimbursement policy for physicians. Diabetes Care. 1993;16:1268-1275.
24. Peters AL, Davidson MB. Application of a diabetes managed care program: the feasibility of using nurses and a computer system to provide effective care. Diabetes Care. 1998;21:1037-1043.
25. Aubert RE, Herman WH, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. Ann Intern Med. 1998;129:605-612.
26. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Gorthaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285:182-189.
27. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control. Diabetes Care. 2001;24:51-55.
28. Jacobson AM, Adler AG, Derby L, Anderson BJ, Wolfsdorf JI. Clinic attendance and glycemic control: study of contrasting groups of patients with IDDM. Diabetes Care. 1991;14:599-601.
29. Graber AL, Davidson P, Brown A, McRae JR, Wooldridge K. Dropout and relapse during diabetes care. Diabetes Care. 1992;15:1477-1483.
30. Slocum W, Ziemer DC, Culler SD, Cook CB, Ferguson SY. Poor appointment keeping behavior worsens glycemic control [abstract]. Diabetes. 1999;48:A197.
31. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
32. Harris MI, Eastman RC, Cowie C, Flegal K, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999;22:403-408.
33. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med. 1996;125:221-232.
34. Beckles GL, Engelgau MM, Narayan KMV, Herman WH, Aubert RE, Williamson DF. Population-based assessment of the level of care among adults with diabetes in the US. Diabetes Care. 1998;21:1432-1438.
35. Holahan J, Brennan N. Who are the adult unisured? Urban Inst. 2000;B-14:1-7.
36. Staveig S, Wigton A. Racial and ethnic disparities: key findings from the national srurvey of America's families. Urban Inst. 2000;B-5:1-5.
37. Ziemer DC, Goldschmid M, Musey VC, et al. Diabetes in urban African-Americans, III: management of type ii diabetes in a municipal hospital setting. Am J Med. 1996;101:25-33.
38. Cook CB, Ziemer DC, El-Kebbi IM, et al. Diabetes in urban African-Americans, XVI: overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22:1494-1500.
39. Cook CB, Lyles RH, El-Kebbi IM, et al. The potentially poor response to outpatient diabetes care in urban African-Americans. Diabetes Care. 2001;24:209-215.
40. El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS. Comorbidity and glycemic control in patients with type 2 diabetes. Arch Intern Med. 2001;161:1295-1300.
41. El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS. Young age as a risk factor for poor glycemic control in urban African-Americans with type 2 diabetes. Arch Intern Med. 2003;163:69-75.
42. Umpierrez GE, Casals MM, Gebhart SS, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes. 1995;44:790-795.
43. Umpierrez GE, Kelly JP, Navarrete JE, Casals MC, Kitabchi AE. Hyperglycemic crisis in urban blacks. Arch Intern Med. 1997;157:669-675.
44. Umpierrez GE, Clark WS, Steen MT. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care. 1997;20:479-483.
45. Institute of Medicine. Care Without Coverage: Too Little, Too Late. Washington, DC: National Academy Press; 2002.
46. Zuber PL, Dignam TA, Caldwell B, Weisner PJ. The burdens of uninsured hospitalizations in an urban county. Eff Clin Pract. 2000;3:131-137.
47. Holahan J, Spillman B. Health Care Access for uninsured adults: a strong safety net is not the same as insurance. Urban Inst. 2002;B-42:1-7.
48. Davidoff A, Garrett B, Yemane A. Medicaid-eligible adults who are not enrolled: who are they and do they get the care they need? Urban Inst. 2001; A-48:1-7.